Global Advanced Wound Care and Closure Market is expected to garner $20.5 billion by 2020, registering a CAGR of 8.0% during the forecast period 2014 - 2020.
Traditional wound care & closure and advanced wound care & closure products are used to treat acute and chronic wounds. Chronic wounds are hard to heal wounds, which take substantial time to heal and are expensive to treat.
Advanced wound care & closure products are emerging as a standard solution for treating chronic wounds. Traditional wound care & closure products are being increasingly substituted with advanced wound care & closure products due to their efficacy and effectiveness in managing wounds by enabling faster healing. This is set to propel the growth of advanced wound care and closure market in near future.
Attempts to reduce the duration of hospital stays in order to limit surgical healthcare costs, and the rising inclination towards products that enhance therapeutic outcomes are driving the demand for advanced wound care & closure products. The risks associated with ineffective wound healing promote the demand for combination dressings, which is a modern trend in the market that is replacing traditional wound dressing methods further supplementing the advanced wound care and closure market growth.
Smith and Nephew, Kinetic Concepts, 3M, BSN medical, Covidien, ConvaTech, Derma Sciences, Integra LifeSciences, Baxter International and Coloplast are some of the major players in the global advanced wound care and closure market.
The global advanced wound care and closure market has been segmented based on type, application, end users and geography. Based on type, the global market is segmented into advanced wound closure market and advanced wound care market. According to applications, the market is segmented into Burns, Ulcers and Surgical Wounds. Based on end users, the market is segmented into hospitals & community healthcare services and home healthcare. Geographically, the market is segmented into four regions, namely North America, Europe, Asia-Pacific and LAMEA.
ADVANCED WOUND CARE AND CLOSURE MARKET KEY BENEFITS
ADVANCED WOUND CARE AND CLOSURE MARKET KEY SEGMENTS
Global advanced wound care and closure market is categorized into types, applications, end user and geography.
BY TYPE
BY APPLICATION
BY END-USER
BY GEOGRAPHY
TABLE OF CONTENT:
CHAPTER 1INTRODUCTION
1.1 Report Description
1.2 Reason for doing study
1.3 Key Benefits
1.4 Key Market Segments
1.5 Key Audiences
1.6 Research Methodology
1.6.1 Secondary research
1.6.2 Primary research
1.6.3 Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
2.1 CXO Perspective
2.2 Market beyond: What to expect by 2025
2.2.1 Moderate Growth Scenario
2.2.2 Rapid growth Scenario
2.2.3 Diminishing growth scenario
CHAPTER 3 GLOBAL ADVANCED WOUND CARE AND WOUND CLOSURE MARKET OVERVIEW
3.1 Market Definition and Scope
3.2 Treatment of diabetic foot ulcers with Negative Pressure Wound Therapy using vaccum-assisted closure and advanced moist wound therapy
3.3 Emergence of combination dressings
3.4 Biologics : An emerging area of Advanced wound care
3.5 Key Findings
3.5.1 Top factors impacting Global Advanced Wound closure and wound care market
3.5.2 Top winning strategies in the Global Advanced wound closure and wound care market
3.5.3 Top investment pockets in advanced wound closure and wound care market
3.6 Value chain analysis
3.7 Porter’s five forces analysis
3.8 Market share analysis, 2013
3.9 Case Studies
3.9.1 Use of IntraSite Conformable dressing in the management of a sloughy venous leg ulcer
3.9.2 IntraSite Conformable in the treatment of necrotic pressure ulcers
3.9.3 INTEGRA WOUND MATRIX DRESSINGS IN TYPE II DIABETIC ULCER
3.10 Global advanced wound care and wound closure market Dynamics
3.10.1 Drivers
3.10.1.1 Increase in aging population
3.10.1.2 Rise in prevalence of chronic wounds, venous ulcers,diabetic ulcers and pressure sores
3.10.1.3 Advancement in technology
3.10.1.4 Increase in volume of Surgeries
3.10.2 Restraints
3.10.2.1 Unfavourable reimbursement policies
3.10.2.2 reluctance in adoption of New technologies
3.10.3 Opportunities
3.10.3.1 Advancements in Moist dressing
3.10.3.2 Optimised physical therapies
3.10.3.3 Biological products
CHAPTER 4 ADVANCED WOUND CARE AND WOUND CLOSURE MARKET BY TYPES
4.1 Advanced Wound Closure
4.1.1 Key market trends
4.1.2 Key drivers and opportunities
4.1.3 Market size and forecast
4.1.4 Haemostatic and sealing agent
4.1.4.1 Surgical Sealant
4.1.4.2 Fibrin Sealant
4.1.4.3 Gelatin-based sealant
4.1.4.4 Human fibrinogen and thrombin fleece (HFTF)
4.1.5 Topical tissue adhesive
4.1.6 Wound closure devices
4.1.6.1 Mechanical Stapling device
4.1.6.2 Ligating clips
4.1.6.3 Wound Closure Strips
4.1.6.4 Others
4.2 Advanced Wound care
4.2.1 Key market trends
4.2.2 Key drivers and opportunities
4.2.3 Market size and forecast
4.2.4 Moist Wound dressings
4.2.4.1 Films
4.2.4.2 Foams
4.2.4.3 Hydrocolloids
4.2.4.4 Hydrogels
4.2.4.5 Collagen
4.2.4.6 Alginate Dressings
4.2.4.7 Silver wound dressings
4.2.5 Active Wound care
4.2.5.1 Skin Substitutes
4.2.5.2 Growth Factors
4.2.6 Therapy devices
4.2.6.1 Negative Pressure wound therapy
4.2.6.2 Pressure Relief devices
4.2.6.3 Others
CHAPTER 5 GLOBAL ADVANCED WOUND CARE AND ADVANCED WOUND CLOSURE MARKET BY APPLICATION
5.1 Burns
5.2 Ulcers
5.2.1 Pressure ulcers
5.2.2 Diabetic foot Ulcers
5.2.3 Venous Ulcers
5.2.4 Arterial Ulcers
5.3 Surgical Wounds
5.4 Others
CHAPTER 6 GLOBAL ADVANCED WOUND CARE AND WOUND CLOSURE MARKET BY END USER
6.1 Hospitals & Community Health Services
6.2 Home Healthcare
CHAPTER 7 GLOBAL ADVANCED WOUND CARE AND WOUND CLOSURE MARKET BY GEOGRAPHY
7.1 North America
7.1.1 Key Market Trends
7.1.2 Competitive Scenario
7.1.3 Key growth factors and opportunities
7.1.4 Market size and Forecast
7.2 Europe
7.2.1 Key market trends
7.2.2 Competitive Scenario
7.2.3 Key growth factors and opportunities
7.2.4 Market Size and Forecast
7.3 Asia Pacific
7.3.1 Key market trends
7.3.2 Competitive Scenario
7.3.3 Key growth factors and opportunities
7.3.4 Market Size and Forecast
7.4 LAMEA
7.4.1 Key market trends
7.4.2 Competitive Scenario
7.4.3 Key growth factors and opportunities
7.4.4 Market Size and Forecast
CHAPTER 8 COMPANY PROFILE
8.13 M
8.1.1 Company overview
8.1.2 Company Snapshot
8.1.3 Business Performance
8.1.4 Strategy move and development
8.1.5 SWOT Analysis of 3M
8.2 BSN Medical
8.2.1 Company overview
8.2.2 Company snapshot
8.2.3 Strategic move and development
8.2.4 SWOT Analysis of BSN Medical
8.3 Covidien
8.3.1 Company overview
8.3.2 Company snapshot
8.3.3 Business Performance
8.3.4 Strategic move and development
8.3.5 SWOT Analysis of Covidien
8.4 Kinetic Concepts
8.4.1 Company Overview
8.4.2 Company snapshot
8.4.3 Business performance
8.4.4 Strategic move and development
8.4.4.1 Primary Strategy: Product launch
8.4.4.2 Secondary Strategy : Acquisition
8.4.5 SWOT Analysis of Kinetic Concepts
8.5 ConvaTech
8.5.1 Company Overview
8.5.2 Company Snapshot
8.5.3 Business Performance
8.5.4 Strategic move and development
8.5.4.1 Principle strategy Product launch
8.5.4.2 Secondary strategy Acquisitions
8.5.5 SWOT Analysis ConvaTech
8.6 Coloplast
8.6.1 Company Overview
8.6.2 Company Snapshot
8.6.3 Business Performance
8.6.4 Strategic move and development
8.6.5 SWOT Analysis of Coloplast
8.7 Derma Sciences
8.7.1 Company overview
8.7.2 Company snapshots
8.7.3 Business Performance
8.7.4 Strategy move and development
8.7.4.1 Principle strategy: Product launch
8.7.4.2 Secondary strategy: Acquisition
8.7.5 SWOT Analysis of Derma Sciences
8.8 Integra LifeSciences
8.8.1 Company overview
8.8.2 Company Snapshot
8.8.3 Business performance
8.8.4 Strategic move and development
8.8.4.1 Principle strategy product launch
8.8.4.2 Secondary strategy acquisition
8.8.5 SWOT Analysis of Integra LifeSciences
8.9 Baxter International
8.9.1 Company Overview
8.9.2 Company Snapshot
8.9.3 Business Performance
8.9.4 Strategic move and development
8.9.4.1 Principle strategy:p product launch
8.9.4.2 Secondary strategy: Research and development
8.9.5 SWOT Analysis of Baxter International
8.10 Smith & Nephews
8.10.1 Company Overview
8.10.2 Company Snapshot
8.10.3 Business Performance
8.10.4 Strategic move and development
8.10.4.1 Principle strategy Product launch
8.10.4.2 Secondary Strategy Acquisitions
List of Tables
TABLE 1 BASE CASE ADVANCED WOUND CARE AND WOUND CLOSURE MARKET REVENUE BY GEOGRAPHY, 2020-2025 ($MILLION)
TABLE 2 OPTISMITICS CASE ADVANCED WOUND CARE AND WOUND CLOSURE MARKET REVENUE BY GEOGRAPHY, 2020-2025 ($MILLION)
TABLE 3 CRITICAL CASE ADVANCED WOUND CARE AND WOUND CLOSURE MARKET REVENUE BY GEOGRAPHY, 2020-2025 ($MILLION)
TABLE 4 GLOBAL ADVANCED WOUND CLOSURE MARKET REVENUE BY TYPE, 2013-2020 ($MILLION)
TABLE 5 GLOBAL HAEMOSTATICS AND SEALING ADVANCED WOUND CLOSURE MARKET REVENUE BY TYPE, 2013-2020 ($MILLION)
TABLE 6 GLOBAL HAEMOSTATICS AND SEALING ADVANCED WOUND CLOSURE MARKET REVENUE BY GEOGRAPHY, 2013-2020 ($MILLION)
TABLE 7 GLOBAL SURGICAL HAEMOSTATICS AND SEALING AGENTS MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 8 GLOBAL FIBRIN HAEMOSTATICS AND SEALING AGENTS MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 9 GLOBAL GELATIN-BASED HAEMOSTATICS AND SEALING AGENTS MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 10 GLOBAL HFTF HAEMOSTATICS AND SEALING AGENTS MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 11 GLOBAL TOPICAL TISSUE ADHESIVES ADVANCED WOUND CLOSURE MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 12 GLOBAL WOUND CLOSURE DEVICES MARKET REVENUE BY TYPE, 2013-2020 ($MILLION)
TABLE 13 GLOBAL WOUND CLOSURE DEVICES MARKET REVENUE BY GEOGRAPHY, 2013-2020 ($MILLION)
TABLE 14 GLOBAL MECHANICAL STAPLING WOUND CLOSURE DEVICES MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 15 GLOBAL LIGATING CLIPS WOUND CLOSURE DEVICES MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 16 GLOBAL WOUND CLOSURE STRIPS WOUND CLOSURE DEVICES MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 17 GLOBAL OTHERS WOUND CLOSURE DEVICES MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 18 GLOBAL ADVANCED WOUND CLOSURE MARKET REVENUE BY TYPE, 2013-2020 ($MILLION)
TABLE 19 GLOBAL ADVANCED WOUND CARE MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 20 GLOBAL FILMS MOIST WOUND DRESSINGS MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 21 GLOBAL FOAMS MOIST WOUND DRESSINGS MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 22 GLOBAL HYDROCOLLOIDS MOIST WOUND DRESSINGS MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 23 GLOBAL HYDROGELS MOIST WOUND DRESSINGS MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 24 GLOBAL COLLAGENS MOIST WOUND DRESSINGS MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 25 GLOBAL ALGINATE DRESSINGS MOIST WOUND DRESSINGS MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 26 GLOBAL SILVER WOUND DRESSINGS MOIST WOUND DRESSINGS MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 27 GLOBAL ACTIVE WOUND CARE MARKET REVENUE BY TYPE, 2013-2020 ($MILLION)
TABLE 28 GLOBAL ACTIVE WOUND CARE MARKET REVENUE BY GEOGRAPHY, 2013-2020 ($MILLION)
TABLE 29 GLOBAL SKIN SUBSTITUTES ACTIVE WOUND CARE MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 30 GLOBAL GROWTH FACTORS ACTIVE WOUND CARE MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 31 GLOBAL THERAPYDEVICE MARKET REVENUE BY TYPE, 2013-2020 ($MILLION)
TABLE 32 GLOBAL THERAPY DEVICE MARKET REVENUE BY GEOGRAPHY, 2013-2020 ($MILLION
TABLE 33 GLOBAL NPWT THERAPY DEVICES MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 34 GLOBAL PRESSURE RELIEF THERAPY DEVICES MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 35 GLOBAL NPWT THERAPY DEVICES MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 36 GLOBAL ADVANCED WOUND CLOSURE AND WOUND CARE MARKET REVENUE BY APPLICATION, 2013-2020 ($MILLION)
TABLE 37 GLOBAL BURNS ADVANCED WOUND CARE AND WOUND CLOSURE MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 38 GLOBAL ULCERS ADVANCED WOUND CARE AND WOUND CLOSURE MARKET REVENUE BY TYPE, 2013 – 2020 ($MILLION)
TABLE 39 GLOBAL ULCERS ADVANCED WOUND CARE AND WOUND CLOSURE MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 40 GLOBAL PRESSURE ULCERS APPLICATION MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 41 GLOBAL DIABETIC FOOT ULCERS APPLICATION MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 42 GLOBAL VENOUS ULCERS APPLICATION MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 43 GLOBAL ARTERIAL ULCERS APPLICATION MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 44 GLOBAL SURGICAL WOUNDS ADVANCED WOUND CARE AND WOUND CLOSURE MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 45 GLOBAL SURGICAL WOUNDS APPLICATION MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 46 GLOBAL OTHER APPLICATION MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 47 GLOBAL ADVANCED WOUND CLOSURE AND WOUND CARE MARKET REVENUE BY AN, 2013-2020 ($MILLION)
TABLE 48 GLOBAL ADVANCED WOUND CLOSURE AND WOUND CARE END USER MARKET REVENUE BY GEOGRAPHY, 2013-2020 ($MILLION)
TABLE 49 GLOBAL HOSPITALS & CHS END USER MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 50 GLOBAL HOME HEALTHCARE END USER MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 51 NORTH AMERICA ADVANCED WOUND CARE AND WOUND CLOSURE MARKET REVENUE BY APPLICATION, 2013-2020 ($MILLION)
TABLE 52 EUROPE ADVANCED WOUND CARE AND WOUND CLOSURE MARKET REVENUE BY APPLICATION, 2013-2020 ($MILLION)
TABLE 53 ASIA-PACIFIC ADVANCED WOUND CARE AND WOUND CLOSURE MARKET REVENUE BY APPLICATION, 2013-2020 ($MILLION)
TABLE 54 LAMEA ADVANCED WOUND CARE AND WOUND CLOSURE MARKET REVENUE BY APPLICATION, 2013-2020 ($MILLION)
TABLE 55 3M SNAPSHOT
TABLE 56 BSN SNAPSHOT
TABLE 57 COVIDIEN SNAPSHOT
TABLE 58 KINETIC CONCEPTS SNAPSHOT
TABLE 59 CONVATECH SNAPSHOT
TABLE 60 COLOPLAST SNAPSHOT
TABLE 61 DERMASCIENCES SNAPSHOT
TABLE 62 INTEGRA LIFESCIENCES SNAPSHOT
TABLE 63 BAXTER SNAPSHOT
List of Figures
FIG. 1 TOP IMPACTING FACTOR (2020-2025)
FIG. 2 TOP IMPACTING FACTORS, OPTIMISTIC CASE (2020-2025)
FIG. 3 TOP IMPACTING FACTOR, CRITICAL CASE (2020-2025)
FIG. 4 TOP FACTORS IMPACTING GLOBAL ADVANCED WOUND CLOSURE AND WOUND CARE MARKET, 2013-2020
FIG. 5 TOP WINNING STRATEGIES IN GLOBAL ADVANCED WOUND CLOSURE AND WOUND CARE MARKET, 2013-2020
FIG. 6 VALUE CHAIN ANALYSIS
FIG. 7 PORTER’S FIVE FORCES ANALYSIS
FIG. 8 3M REVENUE BY BUSINESS SEGMENTS
FIG. 9 3M REVENUE BY GEOGRAPHY
FIG. 10 SWOT ANALYSIS OF 3M
FIG. 11 SWOT ANALYSIS OF BSN MEDICAL
FIG. 12 COVIDIEN REVENUE BY BUSINESS SEGMENTS
FIG. 13 COVIDIEN REVENUE BY GEOGRAPHY
FIG. 14 SWOT ANALYSIS OF COVIDIEN
FIG. 15 KINETIC CONCEPTS REVENUE BY BUSINESS SEGMENT
FIG. 16 SWOT ANALYSIS OF KINETIC CONCEPTS
FIG. 17 CONVATECH REVENUE BY BUSINESS SEGMENTS
FIG. 18 SWOT OF CONVATECH
FIG. 19 COLOPLAST REVENUE BY BUSINESS SEGMENTS
FIG. 20 DERMA SCIENCES REVENUE BY BUSINESS SEGMENTS
FIG. 21 SWOT ANALYSIS OF DERMA SCIENCES
FIG. 22 REVENUE BY GEOGRAPHY
FIG. 23 INTEGRA LIFESCIENCES REVENUE BY SEGMENTS IN US
FIG. 24 SWOT ANALYSIS OF INTEGRA LIFESCIENCES
FIG. 25 BAXTER INTERNATIONAL REVENUE BY BUSINESS SEGMENTS
FIG. 26 BAXTER INTERNATIONAL REVENUE BY GEOGRAPHY
FIG. 27 SWOT ANALYSIS OF BAXTER INTERNATIONAL
FIG. 28 SMITH & NEPHEWS REVENUE BY BUSINESS SEGMENTS
FIG. 29 SMITH & NEPHEWS REVENUE BY GEOGRAPHY
FIG. 30 SWOT OF SMITH AND NEPHEWS
$5540
$9280
Add to Cart
Add to Cart
Add to Cart
Add to Cart